カテゴリー： MarketsandMarkets, IT/電子, 世界

強度変調放射線治療の世界市場予測（～2028）：放射線種類別、用途別、エンドユーザー別、地域別

◆英語タイトル：Intensity-modulated Radiotherapy Market by Radiation Type (Photon,Electron Beam, Proton and Carbon-Ion Radiation) Application (Prostate, Lung, Breast), End Users ( Hospitals and Independent Radiotherapy centers), and Region - Global Forecasts to 2028

MarketsandMarketsが発行した調査報告書（MD8796-23）◆商品コード：MD8796-23
◆発行会社（リサーチ会社）：MarketsandMarkets
◆発行日：2023年9月25日
◆ページ数：160
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥1,010,800見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,238,800見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

"世界の強度変調放射線治療市場は、2023年の22億米ドルから2028年には28億米ドルに達すると予測され、予測期間中のCAGRは5.2％で成長"
強度変調放射線治療市場の急成長の予測は、説得力のある利点の合流によって支えられています。特筆すべきは、IMRTの「腫瘍の標的化において卓越した精度を達成する能力」と「健康な組織への付随的な損傷を軽減する能力」が極めて重要な推進力となっていることです。さらに、世界的な癌罹患率の増加は、IMRTを最前線のソリューションと位置づける先進的な治療法に対する需要を増大させています。このような要因が重なることで、市場は堅調な拡大局面を迎えることになり、その結果、今後数年間のIMRT採用の展望が形作られることになります。

"2023-2027年の予測期間で最も高いCAGRを記録する脳腫瘍アプリケーションセグメント"
強度変調放射線治療市場は、用途に基づき、前立腺がん、肺がん、頭頸部がん、乳がん、消化器がん、婦人科がん、その他の用途に区分されます。2022年に最も高い成長率を示すのは乳がんです。乳がんの増加は、加齢要因、BRCA1やBRCA2のような遺伝的要因、乳がんの症例のごく一部に寄与する遺伝的遺伝子変異、ホルモン補充療法の使用、乳がんの割合を増加させる潜在的な要因のいくつかによって見ることができます。乳がんの罹患率は増加しているように見えますが、乳がんの死亡率は早期発見と治療の進歩により低下しています。IMRTは、医師と患者が適切な放射線強度を使用することにより、効率的に細胞を根絶することができます。

"強度変調放射線治療市場2022-2027年、病院セグメントが最大市場シェアを記録"
強度変調放射線治療市場の主なエンドユーザーは病院です。予測期間中、病院のエンドユーザーセグメントが強度変調放射線治療市場で大きな市場シェアを占めると予測されています。病院は、1つの施設内で包括的な医療サービスを提供できることが特徴であり、強度変調放射線治療（IMRT）市場を受ける患者に独特の利便性をもたらします。この利便性は、多様な医療ニーズをひとつ屋根の下に集約することにより、患者が別々の場所で複数の予約を取る必要性を軽減することに起因しています。このようなサービスの戦略的統合は、患者の治療を合理化するだけでなく、好ましい治療オプションとしてのIMRTの魅力を増大させます。その結果、利便性と包括的ケアのシームレスな連携が、病院内での強度変調放射線治療市場の発展と隆盛に大きく貢献しています。

技術の進歩：病院は、強度変調放射線治療市場の統合を成功させるために不可欠な最先端のインフラと技術能力を頻繁に維持しており、必要なリソースをすぐに利用できるようになっています。この極めて重要な特性は、画像誘導放射線治療市場の発展と強化に明確に寄与しています。

"予測期間中、アジア太平洋が市場の大幅な成長率を記録"
予測期間2023-2028年において、アジア太平洋は予測期間中に市場で著しい成長率を記録すると予測されています。アジア太平洋は、インド、中国、日本、オーストラリア、韓国、その他アジア太平洋で構成されています。アジア太平洋（アジア太平洋）地域は、画像誘導放射線治療の市場成長率が大幅に上昇しています。

市場成長のいくつかの要因：
アジア太平洋諸国では人口動態が成熟化しており、治療に関連する副作用を最小限に抑えた効率的ながん治療法が求められています。強度変調放射線治療（IMRT）市場の精密さ主導の特性との共鳴は、市場展望を強化する上で極めて重要な役割を立証しています。
アジア太平洋の病院では多言語による患者ケアを提供しており、強度変調放射線治療（IMRT）市場のような高度な治療へのアクセスも可能なことから、特に多様な患者の間で、この地域に独自の魅力を与えています。このような言語的な包括性と最先端の医療介入の融合は、この地域が好まれている医療目的地としての望ましさを著しく高め、その結果、医療市場の景観における競争力を強化し、IMRTの隆盛を後押ししています。

本レポートの主な参加企業の内訳は以下の通りです：
- 企業タイプ別 ティア1-40％、ティア2-30％、ティア3-30％
- 役職別 Cレベル-27％、ディレクターレベル-18％、その他-55％
- 地域別 北米-50％、ヨーロッパ-20％、アジア太平洋-15％、中南米-10％、中東・アフリカ-5％

同市場における主要企業は、Varian Medical Systems, Inc., Elekta (Sweden), and Accuray Incorporated (US), Hitachi (Japan)などが含まれます。

調査範囲：
- この調査レポートは、強度変調放射線治療市場を放射線の種類、用途、エンドユーザー、地域に基づいて調査しています。
- 市場成長に影響を与える要因（促進要因、阻害要因、機会、課題など）を分析しました。
- 利害関係者向けに市場の機会と課題を評価し、市場リーダー向けに競争環境の詳細を提供します。
- 微小市場の成長動向、展望、世界の強度変調放射線治療市場への貢献に関して調査しています。
- 主要5地域に関して市場セグメントの収益を予測しています。

レポート購入の主な利点：
本レポートは、包括的なデータの徹底的な分析を通じて、強度変調放射線治療市場における投資評価の実行可能性で、この市場の市場リーダー/新規参入者/中小企業を支援し、それによって強固なリスク評価を容易にし、十分な情報に基づいた投資決定を可能にします。用途、エンドユーザー、地域などの詳細な市場細分化により、正確なセグメントターゲティングのためのテーラーメイドの洞察が得られます。また、極めて重要なトレンド、成長触媒、課題、展望を網羅的に評価し、鋭い洞察力で戦略的意思決定を後押しします。

本レポートは、以下のポイントに関する洞察を提供します：
- 強度変調放射線治療市場の成長に影響を与える主な促進要因（がん患者の増加、がん管理に対する政府の取り組みの増加、放射線治療による非侵襲的治療の進歩）、阻害要因（熟練した放射線科医/腫瘍医の不足、画像誘導放射線治療による治療費の高騰、治療のための画像技術の複雑さ）、機会（新興国における主要企業の拡大、発展途上国における医療費の増加）、課題（代替技術の利用可能性）の分析を行っています。
- 製品開発/イノベーション：画像誘導放射線治療市場における今後の技術、研究開発活動、新製品・サービス開始に関する詳細な洞察を掲載しています。
- 市場開発：有利な市場に関する包括的情報-当レポートでは、様々な地域における強度変調放射線治療市場を分析しています。
- 市場の多様化：強度変調放射線治療市場における新製品、未開拓地域、最近の開発、投資に関する詳細情報を提供します。
- 競争力の評価：Siemens Healthineers AG (Germany), Elekta (Sweden), and Accuray Incorporated (US)などの主要企業の市場シェア、成長戦略、サービス内容を詳細に評価します。

1.イントロダクション
2.調査方法
3.エグゼクティブサマリー
4.プレミアムインサイト
5.市場概要
6.強度変調放射線治療の市場分析：用途別
7.強度変調放射線治療の市場分析：放射線種類別
8.強度変調放射線治療の市場分析：エンドユーザー別
9.強度変調放射線治療の市場分析：地域別
10.競争状況
11.企業情報
12.付録

❖ レポートの目次 ❖

1 INTRODUCTION 22
1.1 STUDY OBJECTIVES 22
1.2 MARKET DEFINITION 22
1.2.1 INCLUSIONS AND EXCLUSIONS 22
1.3 STUDY SCOPE 23
1.3.1 MARKET SCOPE 23
1.3.2 REGIONAL SCOPE 23
1.3.3 YEARS CONSIDERED 24
1.3.4 CURRENCY CONSIDERED 24
1.4 RESEARCH LIMITATIONS 24
1.5 STAKEHOLDERS 24
1.6 RECESSION IMPACT: INTENSITY-MODULATED RADIATION THERAPY MARKET 25
2 RESEARCH METHODOLOGY 26
2.1 RESEARCH DATA 26
FIGURE 1 RESEARCH DESIGN 26
2.1.1 SECONDARY RESEARCH 27
2.1.2 PRIMARY RESEARCH 28
2.1.2.1 Primary sources 28
FIGURE 2 KEY DATA FROM SECONDARY SOURCES 29
2.1.2.2 Breakdown of primary sources 29
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 29
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 30
2.2 MARKET SIZE ESTIMATION 30
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 31
2.2.1 BOTTOM-UP APPROACH 31
2.2.1.1 Company revenue estimation 32
FIGURE 6 COMPANY REVENUE ESTIMATION: INTENSITY-MODULATED RADIATION THERAPY MARKET 32
2.2.1.2 Customer-based market estimation 32
FIGURE 7 BOTTOM-UP APPROACH: INTENSITY-MODULATED RADIATION THERAPY MARKET 33
2.2.2 TOP-DOWN APPROACH 33
2.2.3 PRIMARY INTERVIEWS 33
FIGURE 8 TOP-DOWN APPROACH: INTENSITY-MODULATED RADIATION THERAPY MARKET 34
2.3 MARKET ESTIMATION AND DATA TRIANGULATION 35
FIGURE 9 DATA TRIANGULATION METHODOLOGY 36
2.4 MARKET SHARE ASSESSMENT 36
2.5 ASSUMPTIONS 37
2.5.1 STUDY ASSUMPTIONS 37
2.5.2 ASSUMPTIONS FOR GROWTH FORECAST MODEL 37
2.6 RISK ASSESSMENT 37
2.7 IMPACT OF RECESSION ON INTENSITY-MODULATED RADIATION THERAPY MARKET 38
3 EXECUTIVE SUMMARY 40
FIGURE 10 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2023 VS. 2028 (USD MILLION) 40
FIGURE 11 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 41
FIGURE 12 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 41
FIGURE 13 INTENSITY-MODULATED RADIATION THERAPY MARKET SHARE, BY REGION, 2022 42
4 PREMIUM INSIGHTS 43
4.1 INTENSITY-MODULATED RADIATION THERAPY MARKET OVERVIEW 43
FIGURE 14 INCREASING PREVALENCE OF CANCER AND GROWING GERIATRIC POPULATION TO DRIVE MARKET 43
4.2 NORTH AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE AND COUNTRY 44
FIGURE 15 PHOTON RADIATION AND US COMMANDED LARGEST MARKET SHARE IN 2022 44
4.3 REGIONAL SNAPSHOT OF INTENSITY-MODULATED RADIATION THERAPY MARKET 45
FIGURE 16 MIDDLE EAST & AFRICA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 45
5 MARKET OVERVIEW 46
5.1 INTRODUCTION 46
5.2 MARKET DYNAMICS 46
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: INTENSITY-MODULATED RADIATION THERAPY MARKET 46
5.2.1 DRIVERS 47
5.2.1.1 Rising prevalence of chronic diseases among all age groups 47
FIGURE 18 NEW CANCER CASES GLOBALLY, 2020 47
5.2.1.2 Advancements in radiation therapy technologies to improve treatment and reduce side effects 47
5.2.1.3 Improved patient outcomes and potential cost savings in long run 48
5.2.1.4 Reduced infection risk and shorter recovery periods with minimal scarring 48
5.2.2 RESTRAINTS 49
5.2.2.1 Dearth of skilled radiologists/oncologists for operating automated radiotherapy equipment 49
5.2.2.2 High cost of intensity-modulated radiation therapy systems 49
5.2.3 OPPORTUNITIES 50
5.2.3.1 Rapid economic development and rising healthcare expenditure across emerging economies 50
5.2.3.2 Growing government and private investments in cancer treatment 50
5.2.3.3 Increased adoption of radiation therapy as primary treatment option for cancer 51
5.2.4 CHALLENGES 52
5.2.4.1 Increased risk of radiation exposure for both patients and healthcare staff 52
5.2.4.2 Increased competition from alternative treatment modalities 52
5.3 KEY STAKEHOLDERS AND BUYING CRITERIA 53
5.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 53
TABLE 1 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR INTENSITY-MODULATED RADIATION THERAPY PRODUCTS 53
5.4 PORTER’S FIVE FORCES ANALYSIS 53
TABLE 2 PORTER’S FIVE FORCES ANALYSIS: INTENSITY-MODULATED RADIATION THERAPY MARKET 53
5.4.1 THREAT OF NEW ENTRANTS 54
5.4.2 THREAT OF SUBSTITUTES 54
5.4.3 BARGAINING POWER OF SUPPLIERS 54
5.4.4 BARGAINING POWER OF BUYERS 54
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 54
5.5 REGULATORY ANALYSIS 55
5.5.1 US 55
TABLE 3 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 56
5.5.2 EUROPEAN COUNTRIES 56
5.5.3 JAPAN 56
TABLE 4 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 57
5.6 REIMBURSEMENT SCENARIO ANALYSIS 57
TABLE 5 CPT CODES FOR MAJOR INTENSITY-MODULATED RADIATION THERAPY PROCEDURES 57
TABLE 6 FREESTANDING PER COURSE NATIONAL AVERAGE MEDICARE REIMBURSEMENT, 2021 VS. 2022 58
5.7 ECOSYSTEM MARKET MAP 59
FIGURE 19 ECOSYSTEM MARKET MAP: INTENSITY-MODULATED RADIATION THERAPY MARKET 59
5.8 VALUE CHAIN ANALYSIS 59
5.8.1 TECHNOLOGY INNOVATION 60
5.8.2 PROCUREMENT AND PRODUCT DESIGN 60
5.8.3 MARKETING, SALES, AND DISTRIBUTION AND POST-SALES SERVICES 60
FIGURE 20 VALUE CHAIN ANALYSIS: INTENSITY-MODULATED RADIATION THERAPY MARKET 60
5.9 SUPPLY CHAIN ANALYSIS 61
5.9.1 PROMINENT COMPANIES 61
5.9.2 SMALL & MEDIUM-SIZED COMPANIES 61
5.9.3 END USERS 61
FIGURE 21 SUPPLY CHAIN ANALYSIS: INTENSITY-MODULATED RADIATION THERAPY MARKET 61
5.10 PRICING ANALYSIS 62
5.11 PATENT ANALYSIS 62
FIGURE 22 TOP 10 PATENT APPLICANTS IN INTENSITY-MODULATED RADIATION THERAPY MARKET 62
FIGURE 23 TOP 10 PATENT OWNERS IN INTENSITY-MODULATED RADIATION THERAPY MARKET 63
5.12 TECHNOLOGY ANALYSIS 63
TABLE 7 IMPORTANT PRODUCT LAUNCHES IN INTENSITY-MODULATED RADIATION THERAPY MARKET (JANUARY 2015–JUNE 2022) 63
5.13 KEY CONFERENCES AND EVENTS IN 2023–2024 64
TABLE 8 DETAILED LIST OF KEY CONFERENCES AND EVENTS IN INTENSITY-MODULATED RADIATION THERAPY MARKET (2023–2024) 64
6 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION 65
6.1 INTRODUCTION 66
TABLE 9 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 66
6.2 PROSTATE CANCER 66
6.2.1 ADVANCEMENTS IN NONINVASIVE RADIATION THERAPY TECHNOLOGY TO DRIVE MARKET 66
TABLE 10 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2021–2028 (USD MILLION) 67
6.3 BREAST CANCER 67
6.3.1 LIFESTYLE CHANGES AND FOCUS ON EARLY DETECTION THROUGH SCREENING PROGRAMS TO DRIVE MARKET 67
TABLE 11 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR BREAST CANCER, BY REGION, 2021–2028 (USD MILLION) 68
6.4 LUNG CANCER 68
6.4.1 INCREASING RESEARCH AND CLINICAL TRIAL ACTIVITY TO DRIVE MARKET 68
TABLE 12 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR LUNG CANCER, BY REGION, 2021–2028 (USD MILLION) 69
6.5 GASTROINTESTINAL CANCER 69
6.5.1 RISING CONSUMPTION OF SALT-PRESERVED FOOD AND ALCOHOL TO DRIVE MARKET 69
TABLE 13 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR GASTROINTESTINAL CANCER, BY REGION, 2021–2028 (USD MILLION) 69
6.6 BRAIN CANCER 70
6.6.1 NEGLIGENCE IN PRE-SCREENING PROCEDURES TO LIMIT MARKET 70
TABLE 14 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR BRAIN CANCER, BY REGION, 2021–2028 (USD MILLION) 70
6.7 OTHER CANCERS 70
TABLE 15 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR OTHER CANCERS, BY REGION, 2021–2028 (USD MILLION) 71
7 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE 72
7.1 INTRODUCTION 73
TABLE 16 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 73
7.2 PHOTON RADIATION 73
7.2.1 RISING CANCER CASES GLOBALLY TO DRIVE MARKET 73
TABLE 17 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR PHOTON RADIATION, BY REGION, 2021–2028 (USD MILLION) 74
7.3 ELECTRON RADIATION 74
7.3.1 TECHNIQUE LIMITATIONS AND REDUCED TREATMENT EFFECTIVENESS TO LIMIT ADOPTION 74
TABLE 18 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR ELECTRON RADIATION, BY REGION, 2021–2028 (USD MILLION) 74
7.4 PROTON RADIATION 75
7.4.1 EASY, PRECISE DOSAGE DELIVERY TO CANCEROUS TISSUES TO DRIVE USAGE 75
TABLE 19 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR PROTON RADIATION, BY REGION, 2021–2028 (USD MILLION) 75
7.5 CARBON-ION RADIATION 76
7.5.1 NEED FOR SPECIALIZED FACILITIES AND TREATMENT ROOMS FOR HEAVY ION-BASED THERAPIES TO LIMIT MARKET 76
TABLE 20 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR CARBON-ION RADIATION, BY REGION, 2021–2028 (USD MILLION) 76
8 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER 77
8.1 INTRODUCTION 78
TABLE 21 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER, 2021–2028 (USD MILLION) 78
8.2 HOSPITALS 78
8.2.1 RAPID ADOPTION OF INVASIVE TECHNOLOGIES AND INCREASED NUMBER OF CANCER PATIENTS TO DRIVE MARKET 78
TABLE 22 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION) 79
8.3 INDEPENDENT RADIOTHERAPY CENTERS 79
8.3.1 LOWER OVERHEAD COSTS AND SHORTER WAITING PERIOD TO DRIVE MARKET 79
TABLE 23 INTENSITY-MODULATED RADIATION THERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2021–2028 (USD MILLION) 80
9 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY REGION 81
9.1 INTRODUCTION 82
TABLE 24 INTENSITY-MODULATED RADIATION THERAPY MARKET, BY REGION, 2021–2028 (USD MILLION) 82
9.2 NORTH AMERICA 83
FIGURE 24 NORTH AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET SNAPSHOT 83
TABLE 25 NORTH AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 84
TABLE 26 NORTH AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 84
TABLE 27 NORTH AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 85
TABLE 28 NORTH AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER, 2021–2028 (USD MILLION) 85
9.2.1 NORTH AMERICA: RECESSION IMPACT 85
9.2.2 US 86
9.2.2.1 US dominated North American intensity-modulated radiation therapy market in 2022 86
TABLE 29 US: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 86
9.2.3 CANADA 86
9.2.3.1 Increasing prevalence of cancer and high demand for timely diagnosis to drive market 86
TABLE 30 CANADA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 87
9.3 EUROPE 87
TABLE 31 EUROPE: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 87
TABLE 32 EUROPE: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 88
TABLE 33 EUROPE: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 88
TABLE 34 EUROPE: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER, 2021–2028 (USD MILLION) 89
9.3.1 EUROPE: RECESSION IMPACT 89
9.3.2 GERMANY 89
9.3.2.1 Increasing geriatric population and rising life expectancy to drive market 89
TABLE 35 GERMANY: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 90
9.3.3 FRANCE 90
9.3.3.1 Increasing government initiatives for better healthcare practices to drive market 90
TABLE 36 FRANCE: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 90
9.3.4 UK 91
9.3.4.1 High burden of cancer and rising preference for noninvasive cancer management to drive market 91
TABLE 37 UK: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 91
9.3.5 ITALY 91
9.3.5.1 Increasing geriatric population and rising use of noninvasive cancer treatment methods to drive market 91
TABLE 38 ITALY: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 92
9.3.6 SPAIN 92
9.3.6.1 Increasing technological developments in healthcare to drive market 92
TABLE 39 SPAIN: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 92
9.3.7 REST OF EUROPE 93
TABLE 40 REST OF EUROPE: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 93
9.4 ASIA PACIFIC 93
FIGURE 25 ASIA PACIFIC: INTENSITY-MODULATED RADIATION THERAPY MARKET SNAPSHOT 94
TABLE 41 ASIA PACIFIC: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 42 ASIA PACIFIC: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 95
TABLE 43 ASIA PACIFIC: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 96
TABLE 44 ASIA PACIFIC: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER, 2021–2028 (USD MILLION) 96
9.4.1 ASIA PACIFIC: RECESSION IMPACT 96
9.4.2 JAPAN 97
9.4.2.1 Increased geriatric population and presence of well-established healthcare sector to drive market 97
TABLE 45 JAPAN: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 97
9.4.3 CHINA 98
9.4.3.1 Growing prevalence of cancer and developing healthcare infrastructure to drive market 98
TABLE 46 CHINA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 98
9.4.4 INDIA 99
9.4.4.1 Increasing target patient population and rising availability of advanced surgical treatments to drive market 99
TABLE 47 INDIA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 99
9.4.5 AUSTRALIA 99
9.4.5.1 Developing healthcare sector with increasing availability of advanced surgical and imaging procedures to drive market 99
TABLE 48 AUSTRALIA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 100
9.4.6 SOUTH KOREA 100
9.4.6.1 Growing target cancer patient population and increasing awareness of early cancer diagnosis to drive market 100
TABLE 49 SOUTH KOREA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 100
9.4.7 REST OF ASIA PACIFIC 101
TABLE 50 REST OF ASIA PACIFIC: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 101
9.5 LATIN AMERICA 101
TABLE 51 LATIN AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 52 LATIN AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 102
TABLE 53 LATIN AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 103
TABLE 54 LATIN AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER, 2021–2028 (USD MILLION) 103
9.5.1 LATIN AMERICA: RECESSION IMPACT 103
9.5.2 BRAZIL 104
9.5.2.1 Developing healthcare sector and increasing availability of advanced surgical treatments to drive market 104
TABLE 55 BRAZIL: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 104
9.5.3 MEXICO 104
9.5.3.1 Favorable government initiatives and low-cost manufacturing advantages to drive market 104
TABLE 56 MEXICO: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 105
9.5.4 REST OF LATIN AMERICA 105
TABLE 57 REST OF LATIN AMERICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 105
9.6 MIDDLE EAST & AFRICA 106
9.6.1 FAVORABLE GOVERNMENT INITIATIVES AND ECONOMIC GROWTH TO DRIVE MARKET 106
TABLE 58 MIDDLE EAST & AFRICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY RADIATION TYPE, 2021–2028 (USD MILLION) 106
TABLE 59 MIDDLE EAST & AFRICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 107
TABLE 60 MIDDLE EAST & AFRICA: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY END USER, 2021–2028 (USD MILLION) 107
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 107
10 COMPETITIVE LANDSCAPE 108
10.1 OVERVIEW 108
10.2 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS IN INTENSITY-MODULATED RADIATION THERAPY MARKET 108
FIGURE 26 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS IN INTENSITY-MODULATED RADIATION THERAPY MARKET (2019–2023) 109
10.3 REVENUE SHARE ANALYSIS OF KEY PLAYERS 110
FIGURE 27 REVENUE SHARE ANALYSIS OF TOP FIVE PLAYERS (2019–2022) 110
10.4 MARKET SHARE ANALYSIS: INTENSITY-MODULATED RADIATION THERAPY MARKET, BY KEY PLAYER (2022) 110
FIGURE 28 INTENSITY-MODULATED RADIATION THERAPY MARKET SHARE, BY KEY PLAYER, 2022 110
10.5 COMPANY EVALUATION MATRIX FOR PLAYERS (2022) 111
10.5.1 STARS 111
10.5.2 PERVASIVE PLAYERS 111
10.5.3 EMERGING LEADERS 111
10.5.4 PARTICIPANTS 111
FIGURE 29 COMPANY EVALUATION MATRIX FOR PLAYERS IN INTENSITY-MODULATED RADIATION THERAPY MARKET, 2022 112
10.6 COMPETITIVE BENCHMARKING 113
10.6.1 OVERALL COMPANY FOOTPRINT 113
TABLE 61 OVERALL FOOTPRINT ANALYSIS: INTENSITY-MODULATED RADIATION THERAPY MARKET 113
10.6.2 PRODUCT FOOTPRINT 113
TABLE 62 PRODUCT FOOTPRINT ANALYSIS: INTENSITY-MODULATED RADIATION THERAPY MARKET 113
10.6.3 REGIONAL FOOTPRINT 114
TABLE 63 REGIONAL FOOTPRINT ANALYSIS: INTENSITY-MODULATED RADIATION THERAPY MARKET 114
10.7 COMPETITIVE SCENARIOS AND TRENDS (2020–2023) 115
10.7.1 KEY PRODUCT LAUNCHES AND APPROVALS 115
TABLE 64 KEY PRODUCT LAUNCHES AND APPROVALS 115
10.7.2 KEY DEALS 116
TABLE 65 KEY DEALS 116
10.7.3 OTHER KEY DEVELOPMENTS 117
TABLE 66 OTHER KEY DEVELOPMENTS 117
11 COMPANY PROFILES 118
(Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)*
11.1 SIEMENS HEALTHINEERS AG (VARIAN MEDICAL SYSTEMS, INC.) 118
TABLE 67 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 118
FIGURE 30 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2022) 119
11.2 ELEKTA 126
TABLE 68 ELEKTA: COMPANY OVERVIEW 126
FIGURE 31 ELEKTA: COMPANY SNAPSHOT (2022) 127
11.3 ACCURAY INCORPORATED 132
TABLE 69 ACCURAY INCORPORATED: COMPANY OVERVIEW 132
FIGURE 32 ACCURAY INCORPORATED: COMPANY SNAPSHOT (2022) 133
11.4 IBA WORLDWIDE 137
TABLE 70 IBA WORLDWIDE: COMPANY OVERVIEW 137
FIGURE 33 IBA WORLDWIDE: COMPANY SNAPSHOT (2022) 138
11.5 HITACHI, LTD. 141
TABLE 71 HITACHI, LTD.: COMPANY OVERVIEW 141
FIGURE 34 HITACHI, LTD.: COMPANY SNAPSHOT (2021) 142
11.6 MEVION MEDICAL SYSTEMS 144
TABLE 72 MEVION MEDICAL SYSTEMS: COMPANY OVERVIEW 144
11.7 KONINKLIJKE PHILIPS N.V. 147
TABLE 73 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 147
FIGURE 35 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022) 148
11.8 RAYSEARCH LABORATORIES 150
TABLE 74 RAYSEARCH LABORATORIES: COMPANY OVERVIEW 150
FIGURE 36 RAYSEARCH LABORATORIES: COMPANY SNAPSHOT (2022) 151
11.9 BRAINLAB AG 154
TABLE 75 BRAINLAB AG: COMPANY OVERVIEW 154
*Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)* might not be captured in case of unlisted companies.
12 APPENDIX 155
12.1 DISCUSSION GUIDE 155
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 160
12.3 CUSTOMIZATION OPTIONS 162
12.4 RELATED REPORTS 162
12.5 AUTHOR DETAILS 163



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 強度変調放射線治療の世界市場予測（～2028）：放射線種類別、用途別、エンドユーザー別、地域別(Intensity-modulated Radiotherapy Market by Radiation Type (Photon,Electron Beam, Proton and Carbon-Ion Radiation) Application (Prostate, Lung, Breast), End Users ( Hospitals and Independent Radiotherapy centers), and Region - Global Forecasts to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の強度変調放射線治療（IMRT）市場2023-2030：放射線種類別（陽子線、電子線、光子線、炭素イオン線）、用途別（前立腺がん、肺がん、乳がん、脳腫瘍、婦人科がん、消化器がん、その他）、エンドユーザー別（病院、独立放射線治療センター）、地域別
  • がん強度変調放射線治療（IMRT）のグローバル市場展望 2023年-2029年：陽子線、電子線、光子線、炭素イオン線
  • 画像誘導放射線治療（IGRT）の世界市場予測（～2028）：製品別、処置別、用途別、エンドユーザー別、地域別
  • 医療用放射線遮蔽の世界市場予測（～2028）：製品別、ソリューション別、エンドユーザー別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆